SFOSF
Price
$1.96
Change
-$0.01 (-0.51%)
Updated
Jun 2 closing price
Capitalization
10.9B
TCNNF
Price
$4.40
Change
+$0.34 (+8.37%)
Updated
Jul 21 closing price
Capitalization
788.54M
15 days until earnings call
Interact to see
Advertisement

SFOSF vs TCNNF

Header iconSFOSF vs TCNNF Comparison
Open Charts SFOSF vs TCNNFBanner chart's image
Shanghai Fosun Pharmaceutical Group
Price$1.96
Change-$0.01 (-0.51%)
Volume$500
Capitalization10.9B
Trulieve Cannabis
Price$4.40
Change+$0.34 (+8.37%)
Volume$461.54K
Capitalization788.54M
SFOSF vs TCNNF Comparison Chart in %
Loading...
SFOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SFOSF vs. TCNNF commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SFOSF is a Hold and TCNNF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (SFOSF: $1.96 vs. TCNNF: $4.40)
Brand notoriety: SFOSF and TCNNF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SFOSF: 67% vs. TCNNF: 143%
Market capitalization -- SFOSF: $10.9B vs. TCNNF: $788.54M
SFOSF [@Pharmaceuticals: Other] is valued at $10.9B. TCNNF’s [@Pharmaceuticals: Other] market capitalization is $788.54M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SFOSF’s FA Score shows that 1 FA rating(s) are green whileTCNNF’s FA Score has 1 green FA rating(s).

  • SFOSF’s FA Score: 1 green, 4 red.
  • TCNNF’s FA Score: 1 green, 4 red.
According to our system of comparison, both SFOSF and TCNNF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SFOSF’s TA Score shows that 2 TA indicator(s) are bullish while TCNNF’s TA Score has 6 bullish TA indicator(s).

  • SFOSF’s TA Score: 2 bullish, 2 bearish.
  • TCNNF’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TCNNF is a better buy in the short-term than SFOSF.

Price Growth

SFOSF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while TCNNF (@Pharmaceuticals: Other) price change was -2.87% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.21%. For the same industry, the average monthly price growth was +122.77%, and the average quarterly price growth was +69.47%.

Reported Earning Dates

TCNNF is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SFOSF($10.9B) has a higher market cap than TCNNF($789M). TCNNF has higher P/E ratio than SFOSF: TCNNF (120.48) vs SFOSF (11.75). SFOSF YTD gains are higher at: 8.593 vs. TCNNF (-15.115). SFOSF has higher annual earnings (EBITDA): 6.12B vs. TCNNF (187M). SFOSF has more cash in the bank: 16.1B vs. TCNNF (188M). TCNNF has less debt than SFOSF: TCNNF (1.02B) vs SFOSF (30.8B). SFOSF has higher revenues than TCNNF: SFOSF (44.4B) vs TCNNF (1.21B).
SFOSFTCNNFSFOSF / TCNNF
Capitalization10.9B789M1,381%
EBITDA6.12B187M3,274%
Gain YTD8.593-15.115-57%
P/E Ratio11.75120.4810%
Revenue44.4B1.21B3,666%
Total Cash16.1B188M8,564%
Total Debt30.8B1.02B3,011%
FUNDAMENTALS RATINGS
SFOSF vs TCNNF: Fundamental Ratings
SFOSF
TCNNF
OUTLOOK RATING
1..100
449
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
81
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8193
PRICE GROWTH RATING
1..100
7978
P/E GROWTH RATING
1..100
7316
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SFOSF's Valuation (24) in the null industry is somewhat better than the same rating for TCNNF (81). This means that SFOSF’s stock grew somewhat faster than TCNNF’s over the last 12 months.

SFOSF's Profit vs Risk Rating (100) in the null industry is in the same range as TCNNF (100). This means that SFOSF’s stock grew similarly to TCNNF’s over the last 12 months.

SFOSF's SMR Rating (81) in the null industry is in the same range as TCNNF (93). This means that SFOSF’s stock grew similarly to TCNNF’s over the last 12 months.

TCNNF's Price Growth Rating (78) in the null industry is in the same range as SFOSF (79). This means that TCNNF’s stock grew similarly to SFOSF’s over the last 12 months.

TCNNF's P/E Growth Rating (16) in the null industry is somewhat better than the same rating for SFOSF (73). This means that TCNNF’s stock grew somewhat faster than SFOSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SFOSFTCNNF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 5 days ago
53%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
SFOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCNNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCKT3.130.09
+2.96%
Rocket Pharmaceuticals
HNNA12.820.07
+0.55%
Hennessy Advisors
REGCO22.42-0.07
-0.29%
Regency Centers Corp
JANX26.08-0.32
-1.21%
Janux Therapeutics
LSCC52.15-0.88
-1.66%
Lattice Semiconductor Corp

SFOSF and

Correlation & Price change

A.I.dvisor tells us that SFOSF and BIOVF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SFOSF and BIOVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SFOSF
1D Price
Change %
SFOSF100%
N/A
BIOVF - SFOSF
21%
Poorly correlated
N/A
TKPHF - SFOSF
7%
Poorly correlated
+3.82%
PHCUF - SFOSF
7%
Poorly correlated
N/A
SGIOF - SFOSF
5%
Poorly correlated
N/A
TCNNF - SFOSF
3%
Poorly correlated
+8.32%
More

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
+8.32%
GTBIF - TCNNF
82%
Closely correlated
+5.13%
CURLF - TCNNF
78%
Closely correlated
+24.00%
VRNOF - TCNNF
76%
Closely correlated
+9.26%
CRLBF - TCNNF
76%
Closely correlated
+13.02%
TSNDF - TCNNF
75%
Closely correlated
+10.77%
More